共 50 条
New Cholesterol Guidelines for the Management of Atherosclerotic Cardiovascular Disease Risk A Comparison of the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines with the 2014 National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia
被引:18
作者:
Adhyaru, Bhavin B.
[1
]
Jacobson, Terry A.
[2
]
机构:
[1] Emory Univ, Sch Med, Dept Med, Div Gen Internal Med & Geriatr, 49 Jesse Hill Jr Dr, Atlanta, GA 30303 USA
[2] Emory Univ, Sch Med, Dept Med, Lipid Clin & Cardiovasc Risk Reduct Program, 49 Jesse Hill Jr Dr, Atlanta, GA 30303 USA
关键词:
Clinical recommendations;
Guidelines;
Low-density lipoprotein cholesterol (LDL-C);
Atherosclerotic cardiovascular disease (ASCVD);
Dyslipidemia;
Atherogenic cholesterol;
DENSITY-LIPOPROTEIN CHOLESTEROL;
APOLIPOPROTEIN-B;
PRIMARY PREVENTION;
LDL CHOLESTEROL;
HDL CHOLESTEROL;
STATIN THERAPY;
EVENTS;
ROSUVASTATIN;
METAANALYSIS;
REDUCTION;
D O I:
10.1016/j.ecl.2015.09.002
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
This review discusses the 2013 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults and compares it with the 2014 National Lipid Association (NLA) Recommendations for Patient-Centered Management of Dyslipidemia. The review discusses some of the distinctions between the guidelines, including how to determine a patient's atherosclerotic cardiovascular disease risk, the role of lipoprotein treatment targets, the importance of moderate- and high intensity statin therapy, and the use of nonstatin therapy in light of the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) trial.
引用
收藏
页码:17 / +
页数:22
相关论文
共 50 条